Literature DB >> 31706497

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms.

Jason A Trubiano1, David A Ostrov2, Elizabeth J Phillips3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31706497      PMCID： PMC7255914          DOI： 10.1016/j.jaip.2019.07.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  22 in total

1.  HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Sae-Hoon Kim; Myunghwa Kim; Kyung Wha Lee; Sang-Heon Kim; Hye-Ryun Kang; Heung-Woo Park; Young-Koo Jee
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

2.  Methazolamide-induced Stevens-Johnson syndrome: a warning!

Authors:  J B Cotter
Journal:  Arch Ophthalmol       Date:  1998-01

3.  Stevens Johnson syndrome due to Diamox.

Authors:  R N Sud; S S Grewal
Journal:  Indian J Ophthalmol       Date:  1981-07       Impact factor: 1.848

4.  HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.

Authors:  Katherine C Konvinse; Jason A Trubiano; Rebecca Pavlos; Ian James; Christian M Shaffer; Cosmin A Bejan; Ryan J Schutte; David A Ostrov; Mark A Pilkinton; Misha Rosenbach; Jeffrey P Zwerner; Kristina B Williams; Jack Bourke; Patricia Martinez; Francois Rwandamuriye; Abha Chopra; Mark Watson; Alec J Redwood; Katie D White; Simon A Mallal; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol       Date:  2019-02-16       Impact factor: 10.793

5.  Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.

Authors:  J Yun; J Mattsson; K Schnyder; S Fontana; C R Largiadèr; W J Pichler; D Yerly
Journal:  Clin Exp Allergy       Date:  2013-11       Impact factor: 5.018

6.  Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.

Authors:  Jennifer L Goldman; Wen-Hung Chung; Brian R Lee; Chun-Bing Chen; Chun-Wei Lu; Wolfram Hoetzenecker; Robert Micheletti; Sally Usdin Yasuda; David J Margolis; Neil H Shear; Jeffery P Struewing; Munir Pirmohamed
Journal:  Eur J Clin Pharmacol       Date:  2019-03-27       Impact factor: 2.953

7.  HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.

Authors:  F Yang; J Xuan; J Chen; H Zhong; H Luo; P Zhou; X Sun; L He; S Chen; Z Cao; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2015-04-28       Impact factor: 3.550

8.  Severe cutaneous adverse reactions related to systemic antibiotics.

Authors:  Ying-Fang Lin; Chih-Hsun Yang; Hu Sindy; Jing-Yi Lin; Chung-Yee Rosaline Hui; Yun-Chen Tsai; Ting-Shu Wu; Ching-Tai Huang; Kuo-Chin Kao; Han-Chung Hu; Cheng-Hsun Chiu; Shuen-Iu Hung; Wen-Hung Chung
Journal:  Clin Infect Dis       Date:  2014-03-05       Impact factor: 9.079

Review 9.  HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

Authors:  A J Redwood; R K Pavlos; K D White; E J Phillips
Journal:  HLA       Date:  2018-01       Impact factor: 4.513

Review 10.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.